Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion

Janet Neisewander, Laura E. O'Dell, John C. Redmond

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The purpose of this study was to examine whether blockade of either dopamine D1-like or D2-like receptors by selective antagonist administration into the nucleus accumbens (NAc) is sufficient to reverse cocaine-induced locomotion, and to develop a new technique that enables the population of receptors occupied by the antagonists to be quantified. Locomotor activity was assessed in rats that had received bilateral intra-accumbens injections of the D1-selective antagonist SCH-23390 (0-3.0 μg/0.5 μl/side) or the D2/D3-selective antagonist sulpiride (0-1.0 μg/0.5 μl/side), followed 15 min later by injections of saline or cocaine (15 mg/kg, i.p.). To assess receptor occupancy by the antagonists, 105 min prior to sacrifice the rats received intra-accumbens injections of the antagonist, followed 15 min later by an injection of the non-selective irreversible antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 10 mg/kg, i.p.). Receptors were labeled with [3H]SCH-23390 or [3H]sulpiride in sections containing the NAc, and the autoradiograms allowed quantitation of receptors occupied (i.e. protected from EEDQ) by the antagonist given in vivo. Only a dose of 3 μg/side SCH-23390 reversed cocaine-induced locomotion, whereas a dose of 0.5 μg/side did not alter cocaine-induced locomotion despite occupying the same amount of [3H]SCH-23390 binding sites in the NAc. Intermediate doses of 0.1 and 0.3 μg/side sulpiride reversed cocaine-induced locomotion, and also occupied the greatest number of [3H]sulpiride binding sites in the NAc. The results suggest that blockade of D2-like, but not D1-like, receptors in the NAc is sufficient to reverse cocaine-induced locomotion, and also demonstrate the importance of quantifying receptors occupied by drugs administered intracranially.

Original languageEnglish (US)
Pages (from-to)201-212
Number of pages12
JournalBrain Research
Volume671
Issue number2
DOIs
StatePublished - Feb 13 1995

Fingerprint

Dopamine Receptors
Locomotion
Cocaine
Nucleus Accumbens
Sulpiride
Injections
Binding Sites
Drug Receptors
Dopamine
SCH 23390
Population
EEDQ

Keywords

  • Cocaine
  • D1-like
  • D2-like
  • Dopamine receptor
  • Locomotor activity
  • N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline
  • Nucleus accumbens
  • Receptor occupancy
  • SCH-23390
  • Stereotypy
  • Sulpiride

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion. / Neisewander, Janet; O'Dell, Laura E.; Redmond, John C.

In: Brain Research, Vol. 671, No. 2, 13.02.1995, p. 201-212.

Research output: Contribution to journalArticle

@article{d6297cf62c4546ccadde158e60ad2e4b,
title = "Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion",
abstract = "The purpose of this study was to examine whether blockade of either dopamine D1-like or D2-like receptors by selective antagonist administration into the nucleus accumbens (NAc) is sufficient to reverse cocaine-induced locomotion, and to develop a new technique that enables the population of receptors occupied by the antagonists to be quantified. Locomotor activity was assessed in rats that had received bilateral intra-accumbens injections of the D1-selective antagonist SCH-23390 (0-3.0 μg/0.5 μl/side) or the D2/D3-selective antagonist sulpiride (0-1.0 μg/0.5 μl/side), followed 15 min later by injections of saline or cocaine (15 mg/kg, i.p.). To assess receptor occupancy by the antagonists, 105 min prior to sacrifice the rats received intra-accumbens injections of the antagonist, followed 15 min later by an injection of the non-selective irreversible antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 10 mg/kg, i.p.). Receptors were labeled with [3H]SCH-23390 or [3H]sulpiride in sections containing the NAc, and the autoradiograms allowed quantitation of receptors occupied (i.e. protected from EEDQ) by the antagonist given in vivo. Only a dose of 3 μg/side SCH-23390 reversed cocaine-induced locomotion, whereas a dose of 0.5 μg/side did not alter cocaine-induced locomotion despite occupying the same amount of [3H]SCH-23390 binding sites in the NAc. Intermediate doses of 0.1 and 0.3 μg/side sulpiride reversed cocaine-induced locomotion, and also occupied the greatest number of [3H]sulpiride binding sites in the NAc. The results suggest that blockade of D2-like, but not D1-like, receptors in the NAc is sufficient to reverse cocaine-induced locomotion, and also demonstrate the importance of quantifying receptors occupied by drugs administered intracranially.",
keywords = "Cocaine, D1-like, D2-like, Dopamine receptor, Locomotor activity, N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, Nucleus accumbens, Receptor occupancy, SCH-23390, Stereotypy, Sulpiride",
author = "Janet Neisewander and O'Dell, {Laura E.} and Redmond, {John C.}",
year = "1995",
month = "2",
day = "13",
doi = "10.1016/0006-8993(94)01317-B",
language = "English (US)",
volume = "671",
pages = "201--212",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion

AU - Neisewander, Janet

AU - O'Dell, Laura E.

AU - Redmond, John C.

PY - 1995/2/13

Y1 - 1995/2/13

N2 - The purpose of this study was to examine whether blockade of either dopamine D1-like or D2-like receptors by selective antagonist administration into the nucleus accumbens (NAc) is sufficient to reverse cocaine-induced locomotion, and to develop a new technique that enables the population of receptors occupied by the antagonists to be quantified. Locomotor activity was assessed in rats that had received bilateral intra-accumbens injections of the D1-selective antagonist SCH-23390 (0-3.0 μg/0.5 μl/side) or the D2/D3-selective antagonist sulpiride (0-1.0 μg/0.5 μl/side), followed 15 min later by injections of saline or cocaine (15 mg/kg, i.p.). To assess receptor occupancy by the antagonists, 105 min prior to sacrifice the rats received intra-accumbens injections of the antagonist, followed 15 min later by an injection of the non-selective irreversible antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 10 mg/kg, i.p.). Receptors were labeled with [3H]SCH-23390 or [3H]sulpiride in sections containing the NAc, and the autoradiograms allowed quantitation of receptors occupied (i.e. protected from EEDQ) by the antagonist given in vivo. Only a dose of 3 μg/side SCH-23390 reversed cocaine-induced locomotion, whereas a dose of 0.5 μg/side did not alter cocaine-induced locomotion despite occupying the same amount of [3H]SCH-23390 binding sites in the NAc. Intermediate doses of 0.1 and 0.3 μg/side sulpiride reversed cocaine-induced locomotion, and also occupied the greatest number of [3H]sulpiride binding sites in the NAc. The results suggest that blockade of D2-like, but not D1-like, receptors in the NAc is sufficient to reverse cocaine-induced locomotion, and also demonstrate the importance of quantifying receptors occupied by drugs administered intracranially.

AB - The purpose of this study was to examine whether blockade of either dopamine D1-like or D2-like receptors by selective antagonist administration into the nucleus accumbens (NAc) is sufficient to reverse cocaine-induced locomotion, and to develop a new technique that enables the population of receptors occupied by the antagonists to be quantified. Locomotor activity was assessed in rats that had received bilateral intra-accumbens injections of the D1-selective antagonist SCH-23390 (0-3.0 μg/0.5 μl/side) or the D2/D3-selective antagonist sulpiride (0-1.0 μg/0.5 μl/side), followed 15 min later by injections of saline or cocaine (15 mg/kg, i.p.). To assess receptor occupancy by the antagonists, 105 min prior to sacrifice the rats received intra-accumbens injections of the antagonist, followed 15 min later by an injection of the non-selective irreversible antagonist, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ; 10 mg/kg, i.p.). Receptors were labeled with [3H]SCH-23390 or [3H]sulpiride in sections containing the NAc, and the autoradiograms allowed quantitation of receptors occupied (i.e. protected from EEDQ) by the antagonist given in vivo. Only a dose of 3 μg/side SCH-23390 reversed cocaine-induced locomotion, whereas a dose of 0.5 μg/side did not alter cocaine-induced locomotion despite occupying the same amount of [3H]SCH-23390 binding sites in the NAc. Intermediate doses of 0.1 and 0.3 μg/side sulpiride reversed cocaine-induced locomotion, and also occupied the greatest number of [3H]sulpiride binding sites in the NAc. The results suggest that blockade of D2-like, but not D1-like, receptors in the NAc is sufficient to reverse cocaine-induced locomotion, and also demonstrate the importance of quantifying receptors occupied by drugs administered intracranially.

KW - Cocaine

KW - D1-like

KW - D2-like

KW - Dopamine receptor

KW - Locomotor activity

KW - N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline

KW - Nucleus accumbens

KW - Receptor occupancy

KW - SCH-23390

KW - Stereotypy

KW - Sulpiride

UR - http://www.scopus.com/inward/record.url?scp=0028878613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028878613&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)01317-B

DO - 10.1016/0006-8993(94)01317-B

M3 - Article

C2 - 7743209

AN - SCOPUS:0028878613

VL - 671

SP - 201

EP - 212

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -